New drug aims to cut steroid use in lung sarcoidosis
NCT ID NCT05415137
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 3 trial tested a drug called efzofitimod in 268 adults with pulmonary sarcoidosis, a condition that causes lung inflammation. Participants received either the drug or a placebo every 4 weeks for 48 weeks. The main goal was to see if the drug could help people safely reduce their daily steroid dose while controlling their disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
efzofitimod (also called ATYR1923 or KRP-R120)
What this could lead to
If it works, this could help people with pulmonary sarcoidosis reduce their reliance on steroids while keeping symptoms under control.
What could go wrong
This is a completed Phase 3 trial, but results are not yet public. It may not show a meaningful benefit over placebo, and side effects from the drug are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY SARCOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- XTMAB-16 for Pulmonary Sarcoidosis Trial (NCT07680166)
- Acthar Gel for Sarcoidosis: CXCL9 Biomarker Stud NCT02523092
- OATD-01 for Pulmonary Sarcoidosis Trial (NCT06205121)
- FMT for Inflammatory Diseases Trial (NCT04924270)
- Sarcoidosis Medication Adherence Study | NCT05438095
- XTMAB-16 for Pulmonary Sarcoidosis Trial (NCT05890729)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kyorin Investigative Site
Aomori, 036-8563, Japan
-
Kyorin Investigative Site
Fukuoka, 814-0180, Japan
-
Kyorin Investigative Site
Fukushima, 960-1295, Japan
-
Kyorin Investigative Site
Hokkaido, 060-0033, Japan
-
Kyorin Investigative Site
Hokkaido, 060-8648, Japan
-
Kyorin Investigative Site
Hyōgo, 653-0013, Japan
-
Kyorin Investigative Site
Kanagawa, 236-0004, Japan
-
Kyorin Investigative Site
Kanagawa, 236-0051, Japan
-
Kyorin Investigative Site
Miyagi, 980-8574, Japan
-
Kyorin Investigative Site
Okayama, 700-8558, Japan
-
Kyorin Investigative Site
Osaka, 591-8025, Japan
-
Kyorin Investigative Site
Shimane, 693-8501, Japan
-
Kyorin Investigative Site
Shizuoka, 431-3192, Japan
-
Kyorin Investigative Site
Tokyo, 150-8935, Japan
-
Kyorin Investigative Site
Tokyo, 151-8528, Japan
-
aTyr Investigative Site
Birmingham, Alabama, 35294, United States
-
aTyr Investigative Site
Phoenix, Arizona, 85027, United States
-
aTyr Investigative Site
Los Angeles, California, 90033, United States
-
aTyr Investigative Site
Sacramento, California, 95817, United States
-
aTyr Investigative Site
Denver, Colorado, 80206, United States
-
aTyr Investigative Site
Washington D.C., District of Columbia, 20060, United States
-
aTyr Investigative Site
Gainesville, Florida, 32610, United States
-
aTyr Investigative Site
Tampa, Florida, 33606, United States
-
aTyr Investigative Site
Weston, Florida, 33331, United States
-
aTyr Investigative Site
Atlanta, Georgia, 30308, United States
-
aTyr Investigative Site
Chicago, Illinois, 60611, United States
-
aTyr Investigative Site
Chicago, Illinois, 60612, United States
-
aTyr Investigative Site
Louisville, Kentucky, 40202, United States
-
aTyr Investigative Site
New Orleans, Louisiana, 70115, United States
-
aTyr Investigative Site
Baltimore, Maryland, 21224, United States
-
aTyr Investigative Site
Boston, Massachusetts, 02114, United States
-
aTyr Investigative Site
Ada, Michigan, 49301, United States
-
aTyr Investigative Site
Detroit, Michigan, 48202, United States
-
aTyr Investigative Site
Minneapolis, Minnesota, 55455, United States
-
aTyr Investigative Site
Rochester, Minnesota, 55905, United States
-
aTyr Investigative Site
Jackson, Mississippi, 39216, United States
-
aTyr Investigative Site
St Louis, Missouri, 63110, United States
-
aTyr Investigative Site
Albany, New York, 12208, United States
-
aTyr Investigative Site
Middletown, New York, 10941, United States
-
aTyr Investigative Site
Durham, North Carolina, 27710, United States
-
aTyr Investigative Site
Greenville, North Carolina, 27834, United States
-
aTyr Investigative Site
Cincinnati, Ohio, 45219, United States
-
aTyr Investigative Site
Cleveland, Ohio, 44195, United States
-
aTyr Investigative Site
Oklahoma City, Oklahoma, 73104, United States
-
aTyr Investigative Site
Portland, Oregon, 97220, United States
-
aTyr Investigative Site
Philadelphia, Pennsylvania, 19140, United States
-
aTyr Investigative Site
Charleston, South Carolina, 29425-0630, United States
-
aTyr Investigative Site
Dickson, Tennessee, 37055, United States
-
aTyr Investigative Site
Dallas, Texas, 75246, United States
-
aTyr Investigative Site
Dallas, Texas, 75390, United States
-
aTyr Investigative Site
Houston, Texas, 77030, United States
-
aTyr Investigative Site
Salt Lake City, Utah, 84132, United States
-
aTyr Investigative Site
Falls Church, Virginia, 22042, United States
-
aTyr Investigative Site
Richmond, Virginia, 23298, United States
-
aTyr Investigative Site
Salvador, Estado de Bahia, 40220-005, Brazil
-
aTyr Investigative Site
Porto Alegre, Rio Grande do Sul, 90020-090, Brazil
-
aTyr Investigative Site
São Bernardo do Campo, 09780-000, Brazil
-
aTyr Investigative Site
São Paulo, 04039-901, Brazil
-
aTyr Investigative Site
São Paulo, 05403-900, Brazil
-
aTyr Investigative Site
Bobigny, 93000, France
-
aTyr Investigative Site
La Tronche, 38700, France
-
aTyr Investigative Site
Montpellier, 34295, France
-
aTyr Investigative Site
Paris, 75015, France
-
aTyr Investigative Site
Toulouse, 31000, France
-
aTyr Investigative Site
Essen, 45122, Germany
-
aTyr Investigative Site
Freiburg im Breisgau, 79106, Germany
-
aTyr Investigative Site
Hanover, 30625, Germany
-
aTyr Investigative Site
Heidelberg, 69126, Germany
-
aTyr Investigative Site
Catania, 95124, Italy
-
aTyr Investigative Site
Florence, 50134, Italy
-
aTyr Investigative Site
Forlì, 47121, Italy
-
aTyr Investigative Site
Milan, 20123, Italy
-
aTyr Investigative Site
Naples, 80131, Italy
-
aTyr Investigative Site
Padua, 35128, Italy
-
aTyr Investigative Site
Rome, 00168, Italy
-
aTyr Investigative Site
Siena, 53100, Italy
-
aTyr Investigative Site
Trieste, 34149, Italy
-
aTyr Investigative Site
Kumamoto, 860-8556, Japan
-
aTyr Investigative Site
Nieuwegein, 3435CM, Netherlands
-
aTyr Investigative Site
Barcelona, 08036, Spain
-
aTyr Investigative Site
Barcelona, 08907, Spain
-
aTyr Investigative Site
Madrid, 28006, Spain
-
aTyr Investigative Site
Madrid, 28031, Spain
-
aTyr Investigative Site
Santander, 39008, Spain
-
aTyr Investigative Site
Valencia, 46010, Spain
-
aTyr Investigative Site
Birmingham, B15 2TH, United Kingdom
-
aTyr Investigative Site
Cambridge, CB233RE, United Kingdom
-
aTyr Investigative Site
Cottingham, HU16 5JQ, United Kingdom
-
aTyr Investigative Site
Coventry, CV2 2DX, United Kingdom
-
aTyr Investigative Site
London, SE59RS, United Kingdom
-
aTyr Investigative Site
London, SW3 6NP, United Kingdom